Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?

被引:0
作者
A. M. Medeiros
M. Bourbon
机构
[1] Instituto Nacional de Saúde Doutor Ricardo Jorge,Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde E Prevenção de Doenças Não Transmissíveis
[2] Universidade de Lisboa,BioISI – Biosystems & Integrative Sciences Institute, Faculdade de Ciências
来源
Current Atherosclerosis Reports | 2023年 / 25卷
关键词
Familial hypercholesterolemia; FH; Dyslipidemia; LDLR; FH screening; High cholesterol;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:127 / 132
页数:5
相关论文
共 195 条
[1]  
Beheshti SO(2020)Worldwide prevalence of familial hypercholesterolemia J Am Coll Cardiol 75 2553-2566
[2]  
Madsen CM(2016)Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia J Am Coll Cardiol 67 2578-2589
[3]  
Varbo A(2018)Overview of the current status of familial hypercholesterolaemia care in over 60 countries - the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Atherosclerosis 277 234-255
[4]  
Nordestgaard BG(2021)Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Lancet 398 1713-1725
[5]  
Khera AV(2019)20-Year follow-up of statins in children with familial hypercholesterolemia N Engl J Med 381 1547-1556
[6]  
Won H-H(2008)Efficacy of statins in familial hypercholesterolaemia: a long term cohort study BMJ 11 337-2437
[7]  
Peloso GM(2015)Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Eur Heart J 36 2425-680
[8]  
Lawson KS(2018)Clinical genetic testing for familial hypercholesterolemia J Am Coll Cardiol 72 662-187
[9]  
Bartz TM(2020)Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries Atherosclerosis 292 178-675
[10]  
Deng X(2022)Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States J Clin Lipidol 16 667-524